Okta, Inc. Class A (OKTA) Dividend History

Company News

• These Stocks Could Be Eyeing a Sharp Rebound After Technical Pullbacks

  Several stocks in the US market have recently experienced short-term pullbacks, even as their overall upward trends remain intact. These are not signs of a breakdown, but rather healthy corrections within a longer growth trajectory, often creating attractive entry points for investors.

  Investing.com

  Featured Companies: LCID MOH
• 2 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $450 in June 2025

  Software stocks have outperformed hardware stocks year-to-date, and this trend is expected to continue due to investor concerns about tariffs. Snowflake and Okta, leaders in database management and identity/access management respectively, are well-positioned to benefit from this trend and are projected to see further upside.

  The Motley Fool

  Featured Companies: SNOW
• Buy The Dip in Okta, There’s Nothing Wrong With the Outlook

  Okta's Q1 earnings were solid, with revenue growth and margin expansion. While the full-year guidance is cautious, analysts remain bullish, with the consensus price target rising. The stock's recent decline may present a buying opportunity.

  Investing.com
• Security, Sports, and Skiing

  The article discusses the recent earnings reports of Okta, Dick's Sporting Goods, and Vail Resorts. Okta reported strong revenue growth and profitability, but the stock declined due to high expectations. Dick's Sporting Goods maintained guidance despite tariff challenges, while Vail Resorts saw a leadership change that was well-received by the market.

  The Motley Fool

  Featured Companies: DKS MTN
• Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio?

  Several large-cap stocks, including PDD Holdings, Regeneron Pharmaceuticals, and Burlington Stores, were among the top losers last week, with declines ranging from 11.9% to 29.3%. The reasons for the losses varied, from mixed clinical trial results to earnings misses and tariff concerns.

  Benzinga

  Featured Companies: BAH BURL COO CPRT DECK HPQ REGN SMMT TPL